News / Health

Synthetic Malaria Drug Made Through Biotech, Yeast

A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el-Ghazal, June 1, 2012.
A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el-Ghazal, June 1, 2012.
Jessica Berman
The World Health Organization says more than 200 million people - mostly in sub-Saharan Africa - were infected with malaria in 2010.  The mosquito-borne parasitic illness annually kills 650,000 people, a majority of them young children.

The most effective anti-malaria treatment developed so far is artemisinin, a plant-derived drug that is expensive and often unavailable.  Now, after a decade-long research effort, scientists have found a novel way to cheaply mass-produce artemisinin. The new, bio-synthetic version of the drug could be a major advance in the battle against malaria.

Whenever he travels to Africa, Jack Newman says he arrives prepared with his own supply of artemisinin.

“I always keep it in my back pocket in case I get malaria," said Newman. "Again, in three days you are cured.”

The American researcher hopes others infected with the parasitic illness might soon have easy access to the drug, too.

Newman is co-founder of Amyris, a U.S. biotechnology company that, in collaboration with researchers at the University of California Berkeley and the Canadian National Research Council, developed a process for making large quantities of a semi-synthetic version of artemisinin, offering people with uncomplicated malaria a cure in just three days.  

Artemisinin is a compound that until now has been derived exclusively from an ancient, bitter herb called wormwood.  It is up to 95 percent effective in curing uncomplicated malaria infections but, because it is derived from a plant, artemisinin is frequently in short supply, and expensive.

Newman and his colleagues figured out a way to make an unlimited supply of artemisinin using a technique that combines biotechnology and a simple yeast fermentation process.  

He says they extracted DNA from the wormwood plant and inserted it into yeast cells …

“..to fire up a big fermentation, like beer fermentation, but instead of making beer, you are actually making [an] anti-malarial drug," he said. "And you can do it in hundreds of thousands of gallons and, of course, make it in an industrial fashion, the same way we make penicillin;  very, very inexpensively.”

The process yields a chemical precursor to artemisinin, which is used in the production of the drug.

The innovation was made possible in large part by grants totaling $53.3 million from the Bill and Melinda Gates Foundation to the drug development arm of PATH, an international non-profit group that has been leading the fight against malaria and other diseases.  PATH helped move the artemisinin research out of the UC Berkeley labs to Amyris for scale-up, and then to the pharmaceutical company Sanofi Pasteur, for production of the yeast-based artemisinin. The company says it is distributing the drug free of charge.

Sanofi also plans to share the recipe with other drug makers so they, too, can use the technology to manufacture and distribute it on a “no profit, no loss” basis, according to Amyris's Jack Newman.

“Basically, by using synthetic biology, we’ve been able to stabilize the production so there’s always material available and make it at a very low cost," he said.

Newman says the yeast-based drug is identical to plant-derived artemisinin in terms of effectiveness. It is being formulated with a second anti-malaria compound to reduce the chances of drug resistance.

So far, Newman says, Sanofi plans to make 70 million doses of what he calls malaria “cures” this year. Using synthetic biology, next year the company will scale up production to 120 million doses, which will be distributed globally pending World Health Organization approval.

Jack Newman and his colleagues describe their production of a semi-synthetic version of the anti-malarial drug artemisinin in an article published in the journal Nature.  

You May Like

Video Five Patients Given Experimental Ebola Drug Said To Be Improving

Experimental drugs have been tried on six people: three Westerners and now, three African pyhysicians More

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As Ukrainian military reclaims control of eastern cities residents rebuild their lives, but many say everyone is being treated with suspicion More

Video In Rural Kenya, Pressure Builds Against Female Circumcision

Girls learn to object; FGM practitioners face penalties from jail sentences to stiff fines More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Five Patients Given Experimental Ebola Drug Said to Be Improvingi
X
Carol Pearson
August 19, 2014 11:43 PM
The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.
Video

Video For Obama, Racial Violence is Personal Issue

The racial violence in the St. Louis suburb of Ferguson is presenting U.S. President Barack Obama with an issue to which he has a deep personal connection. To many Americans, Obama's election as America's first black president marked a turning point in race relations in the United States, and Obama has made ending the violence a policy priority. On Monday he issued a new call for calm and understanding. Luis Ramirez reports from the White House.
Video

Video Clinton-Obama Relationship Could Impact 2016 Election

President Barack Obama and former Secretary of State Hillary Clinton have a long and complicated relationship. That relationship took another turn recently when Clinton criticized the president’s foreign policy. VOA National Correspondent Jim Malone reports there is renewed attention on the Clinton-Obama relationship as Hillary Clinton considers running for
Video

Video Iran Looks to Maintain Influence in Baghdad With New Shia PM

Washington and Tehran share the goal of stopping Syrian-based militants in Iraq. But experts say it's Iran, not the United States, that will most influence how the new government in Baghdad approaches internal reforms and the war in Syria. VOA State Department Correspondent Scott Stearns has the story.

AppleAndroid